Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Orthocell Ltd

OCC
Current price
0.64 AUD -0.02 AUD (-3.03%)
Last closed 0.69 AUD
ISIN AU000000OCC6
Sector Healthcare
Industry Biotechnology
Exchange Australian Securities Exchange
Capitalization 165 731 392 AUD
Yield for 12 month +52.38 %
1Y
3Y
5Y
10Y
15Y
OCC
21.11.2021 - 28.11.2021

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union. The company offers Ortho-ATI, a cell therapy for treatment of chronic tendon injuries; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; Remplir, a collagen scaffold used in peripheral nerve repair; and Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia. Address: Building 191, Murdoch, WA, Australia, 6150

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.85 AUD

P/E ratio

Dividend Yield

Current Year

+5 417 823 AUD

Last Year

+4 324 850 AUD

Current Quarter

+3 985 318 AUD

Last Quarter

+2 606 708 AUD

Current Year

+3 726 699 AUD

Last Year

+3 119 700 AUD

Current Quarter

+3 147 627 AUD

Last Quarter

+1 827 140 AUD

Key Figures OCC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -11 120 081 AUD
Operating Margin TTM -140.87 %
PE Ratio
Return On Assets TTM -25.04 %
PEG Ratio
Return On Equity TTM -134.46 %
Wall Street Target Price 0.85 AUD
Revenue TTM 5 417 822 AUD
Book Value 0.022 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 15.1 %
Dividend Yield
Gross Profit TTM 3 278 916 AUD
Earnings per share -0.041 AUD
Diluted Eps TTM -0.041 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -135.1 %

Dividend Analytics OCC

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History OCC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation OCC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 25.0422
Price Sales TTM 30.3651
Enterprise Value EBITDA -3.8756
Price Book MRQ 33.763

Financials OCC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators OCC

For 52 weeks

0.36 AUD 0.78 AUD
50 Day MA 0.55 AUD
Shares Short Prior Month
200 Day MA 0.43 AUD
Short Ratio
Shares Short
Short Percent